BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02203526-completion@plaintrial.com
DTSTAMP:20261027T011436Z
DTSTART;VALUE=DATE:20270615
SUMMARY:Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomi
 de\, Etoposide\, Doxil\, Dexamethasone\, Ibrutinib\,Rituximab (TEDDI-R) in
  Primary CNS Lymphoma — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02203526
URL:https://plaintrial.com/trial/NCT02203526
END:VEVENT
END:VCALENDAR